ALLERGAN INC
424B2, 1995-06-08
PHARMACEUTICAL PREPARATIONS
Previous: WABAN INC, 10-Q, 1995-06-08
Next: HERITAGE INCOME TRUST, NSAR-A/A, 1995-06-08



<PAGE>   1

Pricing Supplement No. 8 Dated June 6, 1995                      Rule 424(b)(2)
(To prospectus dated March 4, 1994 and                        File No. 33-69746
Prospectus Supplement dated March 4, 1994)


                               [LOGO] ALLERGAN

                        MEDIUM-TERM NOTES - FIXED RATE

<TABLE>
- --------------------------------------------------------------------------------------
<S>                                <C>           <C>                    <C>
Principal Amount:                 $10,000,000           Interest Rate:  5.91%

Agents' Discount or Commission:       $25,000    Stated Maturity Date:  June 12, 1997

Net Proceeds to Issuer:            $9,975,500     Original Issue Date:  June 12, 1995
- --------------------------------------------------------------------------------------
</TABLE>

Interest Payment Dates:  June 15 and December 15

Redemption:

  /x/  The Notes cannot be redeemed prior to the Stated Maturity Date
  / /  The Notes may be redeemed prior to the Stated Maturity Date
       Initial Redemption Date:
       Initial Redemption Percentage:
       Annual Redemption Percentage Reduction: ____% until Redemption Percentage
       is 100% of the principal amount.

Optional Repayment:
  /x/  The Notes cannot be repaid prior to the Stated Maturity Date.
  / /  The Notes can be repaid prior to the Stated Maturity Date at the option
       of the holder of the Notes.
       Optional Repayment Date(s):
       Repayment Price: ____%

Currency:
       Specified Currency: U.S. dollar
         (if other than U.S. dollars, see attached)
       Minimum Denominations:
         (Applicable only if Specified Currency is other than U.S. dollars)

Original Issue Discount:        / / Yes         /x/ No
       Total Amount of OID:
       Yield to Maturity:
       Initial Accrual Period:

Form:   /x/ Book-Entry          / / Certificated

Agent:  /x/ Merrill Lynch & Co.

        /x/ J.P. Morgan Securities Inc.

Agent acting in the capacity as indicated below:
       / / Agent        /x/ Principal

If as principal:
       / / The Notes are being offered at varying prices related to prevailing
           market prices at the time of resale.
       /x/ The Notes are being offered at a fixed initial public offering price
           of 100% of principal amount.

If as Agent:
       The Notes are being offered at a fixed initial public offering price of
       ____% of principal amount.
       

Other Provisions:




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission